These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33737009)

  • 21. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
    Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
    J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
    Abdelrahman MH; Youssif BGM; Abdelgawad MA; Abdelazeem AH; Ibrahim HM; Moustafa AEGA; Treamblu L; Bukhari SNA
    Eur J Med Chem; 2017 Feb; 127():972-985. PubMed ID: 27837994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition.
    Altıntop MD; Sever B; Akalın Çiftçi G; Ertorun İ; Alataş Ö; Özdemir A
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200136. PubMed ID: 35606682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor.
    Imanishi J; Morita Y; Yoshimi E; Kuroda K; Masunaga T; Yamagami K; Kuno M; Hamachi E; Aoki S; Takahashi F; Nakamura K; Miyata S; Ohkubo Y; Mutoh S
    Biochem Pharmacol; 2011 Oct; 82(7):746-54. PubMed ID: 21745460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Kaur A; Pathak DP; Sharma V; Wakode S
    Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical and structural diversity in cyclooxygenase protein active sites.
    Huff RG; Bayram E; Tan H; Knutson ST; Knaggs MH; Richon AB; Santago P; Fetrow JS
    Chem Biodivers; 2005 Nov; 2(11):1533-52. PubMed ID: 17191953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
    Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
    J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
    Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
    J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity.
    Biava M; Porretta GC; Poce G; Supino S; Forli S; Rovini M; Cappelli A; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Vivoli E; Makovec F; Anzellotti P; Patrignani P; Anzini M
    J Med Chem; 2007 Nov; 50(22):5403-11. PubMed ID: 17915854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of dithiolethiones as novel cyclooxygenase inhibitors.
    Zanatta SD; Manallack DT; Jarrott B; Williams SJ
    Bioorg Med Chem Lett; 2009 Jan; 19(2):459-61. PubMed ID: 19056264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors.
    Grover J; Kumar V; Singh V; Bairwa K; Sobhia ME; Jachak SM
    Eur J Med Chem; 2014 Jun; 80():47-56. PubMed ID: 24763362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleiotropic mechanisms facilitated by resveratrol and its metabolites.
    Calamini B; Ratia K; Malkowski MG; Cuendet M; Pezzuto JM; Santarsiero BD; Mesecar AD
    Biochem J; 2010 Jul; 429(2):273-82. PubMed ID: 20450491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docking Studies, Synthesis and Biological Evaluation of β-aryl-β-hydroxy Propanoic Acids for Anti-inflammatory Activity.
    Savic J; Dilber S; Milenkovic M; Kotur-Stevuljevic J; Markovic B; Vladimirov S; Brboric J
    Med Chem; 2017; 13(2):186-195. PubMed ID: 27605092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diarylheterocycle core ring features effect in selective COX-1 inhibition.
    Perrone MG; Vitale P; Malerba P; Altomare A; Rizzi R; Lavecchia A; Di Giovanni C; Novellino E; Scilimati A
    ChemMedChem; 2012 Apr; 7(4):629-41. PubMed ID: 22278975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio.
    Temml V; Kaserer T; Kutil Z; Landa P; Vanek T; Schuster D
    Future Med Chem; 2014; 6(17):1869-81. PubMed ID: 25495981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors.
    Lai Y; Ma L; Huang W; Yu X; Zhang Y; Ji H; Tian J
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7349-53. PubMed ID: 21055929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of wines and wine constituents on cyclooxygenase-1, cyclooxygenase-2, and 5-lipoxygenase catalytic activity.
    Kutil Z; Temml V; Maghradze D; Pribylova M; Dvorakova M; Schuster D; Vanek T; Landa P
    Mediators Inflamm; 2014; 2014():178931. PubMed ID: 24976682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nectandra amazonum-derived flavonoids as COX-1 inhibitors: in vitro and docking studies.
    Valdés-Barrera ID; Cuca-Suarez LE; Coy-Barrera ED
    Nat Prod Commun; 2014 May; 9(5):649-52. PubMed ID: 25026711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
    Zarghi A; Ghodsi R
    Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.